OM:PNDX B
OM:PNDX BReal Estate

Pandox (OM:PNDX B): Assessing Valuation Following Q3 Profit Turnaround and Accelerated Acquisition Plans

Pandox (OM:PNDX B) shares have drawn fresh attention after the company posted a clear jump in net income for the third quarter, shifting from a net loss last year to a solid profit. Alongside the earnings lift, management revealed plans to accelerate acquisitions and indicated that current market conditions could support both buying and selling assets. See our latest analysis for Pandox. Pandox’s latest acquisition push and jump in profits come as its share price has steadily climbed, with a...
OM:BIOG B
OM:BIOG BBiotechs

A Look at BioGaia (OM:BIOG B) Valuation Following Breakthrough Gut-Brain Serotonin Discovery

BioGaia (OM:BIOG B) just shared breakthrough research showing that two gut bacterial strains can generate serotonin, a neurotransmitter mostly made in the intestine. This discovery opens up new avenues for gut-brain health. See our latest analysis for BioGaia. While BioGaia’s serotonin breakthrough has put a spotlight back on its innovation, the stock tells a more nuanced story. After some short-term volatility and a recent earnings beat, the 1-year total shareholder return is nearly flat at...
OM:IVSO
OM:IVSOAerospace & Defense

Invisio (OM:IVSO) Is Down 7.2% After Reporting Third-Quarter Loss and Lower Sales Has The Bull Case Changed?

Invisio AB (publ) recently announced its third-quarter 2025 results, reporting sales of SEK291.3 million and a net loss of SEK4.2 million, compared to sales of SEK351.7 million and net income of SEK38.9 million a year earlier. This marks a shift from profitability to a loss, underscoring a year-over-year deterioration in both sales and earnings performance. Given Invisio's move to a quarterly loss after several years of profitability, we'll evaluate how this development impacts the company's...
OM:SECT B
OM:SECT BHealthcare Services

A Fresh Look at Sectra (OM:SECT B) Valuation Following Region Stockholm's Major Cloud Rollout Decision

Sectra (OM:SECT B) recently shared that Region Stockholm will roll out its enterprise imaging cloud service across all hospitals in Stockholm and Gotland. This step unifies imaging systems and aims for greater security and streamlined healthcare operations. See our latest analysis for Sectra. Sectra’s announcement comes after a year marked by solid long-term gains and some recent volatility. While the share price is up 5.99% year-to-date, a dip of 4.53% over the last week and a 15.29% fall in...
OM:IMP A SDB
OM:IMP A SDBMedical Equipment

Assessing Implantica (OM:IMP A SDB) Valuation Following FDA Progress for RefluxStop Device

Implantica (OM:IMP A SDB) saw momentum build this week after the company received positive feedback from the FDA on its RefluxStop device. Recent inspections wrapped up smoothly and set the stage for potential U.S. market entry. See our latest analysis for Implantica. That FDA feedback has energized investors, but it comes after an intense year of ups and downs for Implantica. Despite a sharp short-term pullback, such as a 25.9% one-month share price return, the stock's 43.7% year-to-date...
OM:GETI B
OM:GETI BMedical Equipment

Getinge (OM:GETI B): Assessing Valuation as Guidance Holds Firm Despite Tariffs and Currency Pressures

Getinge (OM:GETI B) reaffirmed its guidance for 2025, confirming expectations for 2% to 5% organic net sales growth and targeting over 12% earnings per share growth, even with ongoing headwinds from tariffs and currency shifts. See our latest analysis for Getinge. Backed by steady guidance and resilience in the face of tariffs and currency changes, Getinge’s shares have climbed with conviction this year, posting a robust 21.6% year-to-date share price return and an impressive 1-year total...
OM:NYF
OM:NYFReal Estate

Nyfosa (OM:NYF): Valuation in Focus After Earnings Show Return to Profitability

Nyfosa (OM:NYF) has just released its third quarter and nine-month results for 2025, highlighting a return to profitability after a period of losses. This turnaround in earnings is drawing attention from investors who are watching the company’s recovery. See our latest analysis for Nyfosa. Nyfosa’s return to profitability comes at a time when its share price remains under pressure, with a year-to-date decline of 24.27%. While the recent earnings turnaround and moves like the planned...
OM:ATT
OM:ATTHealthcare

A Fresh Look at Attendo (OM:ATT) Valuation After Profitability Outpaces Revenue Decline

Attendo (OM:ATT) has drawn renewed attention after its latest earnings update. While sales and revenue slipped slightly compared to last year, both net income and earnings per share saw significant gains for the quarter and the year to date period. See our latest analysis for Attendo. Attendo’s recent buyback and improving profitability have clearly caught investors’ attention, contributing to the stock’s sharp momentum. The 1-month share price return stands at 17.8%, and total shareholder...
OM:THULE
OM:THULELeisure

Thule Group (OM:THULE): Assessing Valuation After Third-Quarter Sales and Profit Growth

Thule Group (OM:THULE) just released its third-quarter earnings, showing both sales and net income rising compared to last year. That quarterly growth stands out, even as nine-month profits dipped slightly despite higher sales. See our latest analysis for Thule Group. Thule Group’s share price has struggled to regain its footing this year, with a year-to-date share price return of -29.04%. Even after encouraging growth in the latest quarter, the third-quarter sales and profit uptick gave...
OM:NOLA B
OM:NOLA BIndustrials

Nolato (OM:NOLA B): Evaluating Valuation Potential After Earnings Growth Outpaces Sales Decline

Nolato (OM:NOLA B) just released its third quarter and nine-month earnings, showing an uptick in both net income and earnings per share compared to last year, even as sales edged down slightly. Investors are paying close attention. See our latest analysis for Nolato. Nolato’s steady earnings progress has caught the market’s attention, especially as the 1-year total shareholder return sits at 14% and the share price is up nearly 14% year-to-date. While momentum has picked up in recent months,...
OM:SKF B
OM:SKF BMachinery

AB SKF (OM:SKF B) Valuation in Focus After Lower Q3 Results and Cautious Outlook

AB SKF (OM:SKF B) published its third-quarter results, revealing a decline in both sales and net income compared to last year. The company also shared a cautious outlook, highlighting ongoing economic uncertainty and an expected negative impact from currency movements. See our latest analysis for AB SKF. Despite the recent dip in quarterly sales and the announcement of some operational changes, AB SKF’s total shareholder return has climbed an impressive 24% over the past year, outpacing its...
OM:CS
OM:CSCapital Markets

CoinShares’ Launch of Staked Toncoin ETP Could Be a Game Changer for CoinShares International (OM:CS)

CoinShares International recently launched the CoinShares Physical Staked Toncoin, a regulated exchange-traded product providing direct exposure to Toncoin, a blockchain integrated with Telegram's global platform, following its announced merger with Vine Hill Capital Investment Corp. This product stands out by offering 0% management fees and staking yield, leveraging Telegram’s 900 million–plus user base for real-world blockchain utility. We’ll examine how CoinShares’ integration of...
OM:CAMX
OM:CAMXPharmaceuticals

How Investors Are Reacting To Camurus (OM:CAMX) Launching Self-Administered Acromegaly Therapy in Germany

Camurus recently announced the launch of Oczyesa®, a long-acting octreotide subcutaneous depot for maintenance treatment of adult acromegaly patients, now made available for the first time in Germany following European Commission marketing authorization. This marks the introduction of a self-administered therapy for acromegaly in the EU, potentially improving patient convenience and satisfaction while reflecting regulatory momentum for innovative treatments. We’ll now consider how the EU...
OM:BETS B
OM:BETS BHospitality

Sustained Sales and Profit Growth Could Be a Game Changer for Betsson (OM:BETS B)

Betsson AB recently reported its third-quarter and nine-month 2025 earnings, showing sales of €295.8 million and €893.1 million, and net income of €47.6 million and €144.7 million, respectively, all higher than the same periods last year. This sustained growth in both sales and profitability highlights Betsson’s momentum across its primary markets and reflects the company’s focus on expanding its revenue streams while maintaining operational efficiency. We'll now examine how Betsson’s higher...
OM:TELIA
OM:TELIATelecom

Telia Company (OM:TELIA) Valuation in Focus After Mixed Earnings and Recent Share Price Gain

Telia Company (OM:TELIA) released its third quarter earnings, highlighting stable sales and a slight increase in quarterly net income. However, nine-month results reflected lower net income and earnings per share compared to last year. See our latest analysis for Telia Company. Despite Telia's mixed earnings, the stock has maintained upward momentum, with a 5.2% one-month share price return and a strong 19.5% year-to-date increase. Looking to the long term, total shareholder return stands at...
OM:ENGCON B
OM:ENGCON BMachinery

Can Margin Pressures at engcon (OM:ENGCON B) Reshape the Long-Term Growth Narrative?

In late October 2025, engcon AB released its third quarter and nine-month earnings, reporting SEK 415 million in sales and SEK 50 million net income for the third quarter, with annual comparisons showing slight sales growth but a decrease in quarterly net income. While nine-month sales and net income increased compared to the previous year, the third quarter's stronger sales were offset by margin pressures, highlighting ongoing challenges for profitability despite overall expansion. To...
OM:SAAB B
OM:SAAB BAerospace & Defense

How Saab's Upgraded Sales Guidance and NATO Order May Impact OM:SAAB B Investors

Saab recently upgraded its 2025 organic sales growth guidance to 20–24%, highlighting strong order momentum and ongoing capacity expansions, while also reporting a SEK 540 million order from the NATO Support and Procurement Agency for Spain’s Arthur radar systems. An interesting development is Saab’s consideration of Canadian assembly for Gripen fighter jets, aligning with expanding international demand including interest from Ukraine and deepening aerospace partnerships with Canada. We’ll...
OM:MTG B
OM:MTG BEntertainment

Does MTG’s Share Buyback Reflect a Shift in Capital Allocation Priorities for OM:MTG B?

Modern Times Group MTG announced in October 2025 that it had started a share repurchase program, following authorization from its May 2025 Annual General Meeting, with plans to buy back up to 12,203,000 shares, representing 10% of its issued share capital, or spend up to SEK400 million by May 2026. This buyback program allows MTG not only to enhance long-term shareholder value and returns but also to provide shares for its long-term incentive initiatives. With the share buyback program...